Raia Drogasil S.A. (RADLY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Raia Drogasil S.A.

OTC: RADLY · Real-Time Price · USD
3.58
0.19 (5.60%)
At close: Oct 03, 2025, 3:58 PM
3.65
1.96%
After-hours: Oct 03, 2025, 03:58 PM EDT

Raia Drogasil S.A. Income Statement

Financials in BRL. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
40.96B 39.81B 38.86B 37.7B 36.39B 35.14B 33.97B 32.89B 31.7B 30.44B 29.07B 27.7B 26.38B 25.07B 24.13B 23.21B 22.14B 20.74B
Cost of Revenue
28.92B 28.49B 28.2B 27.34B 26.41B 25.03B 23.77B 23.03B 22.21B 21.23B 20.26B 19.28B 18.37B 17.58B 16.92B 16.32B 15.57B 14.65B
Gross Profit
12.04B 11.33B 10.66B 10.36B 9.98B 10.11B 10.21B 9.86B 9.49B 9.2B 8.81B 8.42B 8.01B 7.49B 7.21B 6.89B 6.57B 6.09B
Operating Income
2.41B 2.35B 2.39B 2.72B 2.46B 2.37B 2.12B 1.46B 1.48B 1.47B 1.38B 1.55B 1.36B 1.21B 1.31B 1.21B 1.25B 943.51M
Interest Income
11K 11K 18K 21K 21K 28K 33K 155K 312K 418K 1.2M 1.13M 966K 903K 114K 54K 9.84M 9.85M
Pretax Income
1.32B 1.34B 1.42B 1.43B 1.29B 1.29B 1.22B 1.21B 1.18B 1.26B 1.19B 1.07B 1.02B 882.14M 987.26M 1.02B 996.35M 694.33M
Net Income
1.22B 1.17B 1.2B 1.11B 1.04B 1.05B 1.05B 1.08B 1.03B 1.05B 996.11M 881.24M 820.36M 718.28M 751.93M 743.3M 743.5M 535.42M
Selling & General & Admin
9.68B 9.47B 9.19B 8.94B 8.71B 8.43B 8.19B 7.86B 7.56B 7.28B 7.06B 6.82B 6.51B 6.21B 5.88B 5.59B 5.32B 5.11B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
-53.5M -48.78M -39.93M 2.35M 42.34M 51.2M 57.36M 20.53M 61.3M 101.67M 113.5M 113.5M 72.73M 74.04M 58.1M 58.1M 58.1M n/a
Operating Expenses
9.63B 8.98B 8.28B 8.09B 7.91B 8.07B 8.26B 7.88B 7.53B 7.21B 6.99B 6.74B 6.48B 6.16B 5.83B 5.52B 5.24B 5.08B
Interest Expense
911.67M 814.95M 812.72M 777.3M 743.61M 732.26M 595.37M 551.91M 545.83M 446.86M 426.12M 479.72M 335.37M 319.2M 328.77M 212.54M 281.73M 282.88M
Selling & Marketing Expenses
8.11B 7.89B 7.63B 7.39B 7.16B 6.9B 6.69B 6.42B 6.18B 5.98B 5.81B 5.64B 5.42B 5.21B 4.97B 4.75B 4.55B 4.37B
Cost & Expenses
38.57B 37.49B 36.5B 35.46B 34.31B 33.1B 32.03B 30.9B 29.74B 28.45B 27.25B 26.03B 24.84B 23.74B 22.75B 21.84B 20.81B 19.73B
Income Tax Expense
84.82M 155.08M 206.51M 292.83M 224.75M 210.79M 129.55M 117.66M 136.28M 187.23M 178.24M 162.32M 177.06M 150.32M 223.13M 260.84M 241.06M 146.6M
Shares Outstanding (Basic)
1.65B 1.65B 1.65B 1.65B 1.65B 1.65B 1.71B 1.71B 1.68B 1.71B 1.71B 1.65B 1.65B 1.71B 1.71B 1.72B 1.72B 1.72B
Shares Outstanding (Diluted)
1.66B 1.65B 1.66B 1.66B 1.66B 1.67B 1.71B 1.71B 1.68B 1.75B 1.72B 1.72B 1.66B 1.73B 1.72B 1.72B 1.72B 1.73B
EPS (Basic)
0.74 0.71 0.72 0.66 0.61 0.61 0.61 0.63 0.61 0.63 0.60 0.53 0.49 0.42 0.44 0.43 0.43 0.31
EPS (Diluted)
0.74 0.71 0.72 0.66 0.61 0.61 0.61 0.63 0.61 0.62 0.59 0.52 0.48 0.42 0.44 0.43 0.43 0.31
EBITDA
3.23B 3.11B 3.14B 3.61B 3.36B 3.32B 3.18B 3.52B 3.46B 3.42B 3.22B 3.12B 2.89B 2.64B 2.66B 2.54B 2.44B 2.1B
EBIT
2.22B 2.15B 2.23B 2.23B 2.07B 2.06B 1.95B 1.9B 1.85B 1.86B 1.7B 1.69B 1.55B 1.35B 1.43B 1.27B 1.18B 891.79M
Depreciation & Amortization
1.01B 961.42M 900.92M 1.79B 1.75B 1.7B 1.66B 1.63B 1.57B 1.52B 1.47B 1.43B 1.39B 1.34B 1.29B 1.28B 1.22B 1.19B